Adenosine Triphosphate Disodium
CAS 987-65-5
Adenosine Triphosphate Disodium (CAS 987-65-5) is a pharmaceutical compound with 0 bioactivity targets and 10 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Adenosine Triphosphate Disodium used for in pharmaceutical contexts?
Adenosine Triphosphate Disodium (CAS 987-65-5) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Adenosine Triphosphate Disodium?
Adenosine Triphosphate Disodium has 10 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Adult T-cell lymphoma/leukaemia, Drug interaction, Immune thrombocytopenia, Pneumonia, Swelling face. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Adenosine Triphosphate Disodium also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Disodium Adenosine Triphosphate with EU status "permitted".
What clinical phase is Adenosine Triphosphate Disodium in?
No phase 1-4 clinical development badge is rendered for Adenosine Triphosphate Disodium because the matched compound identifier rows do not contain a max-phase value.